S.V. Nedogoda, MD, PhD, Prof
Nephroprotection in metabolic syndrome
|
№2 / 2009
|
G.E. Gendlin, MD, PhD, Prof; O.A. Ettinger, MD, Ass Prof; E.V. Resnyk, MD; O.A. Tronina, MD; O.A. Solomonova, MD
Ultrasound scanning of kidney: opportunities and limitations
|
№2 / 2009
|
N.A. Moukhin, MD, PhD, Prof
Signs, mimicking chronic glomerulonephritis activity
|
№2 / 2009
|
Acute glomerulonephritis –all questions are answered?
|
№2 / 2009
|
M.V. Lebedeva, MD, PhD
Allopurinol: indications and tactics of prescription
|
№1 / 2009
|
Mukhin N.A., MD, PhD, Prof; Martynov A.I., MD, PhD, Prof; Gyliarevsky S.R., MD, PhD, Prof; Fomin VV, MD, PhD.
Controversies in ACE inhibitors use
|
№1 / 2009
|
N.A. Mukhin, MD, PhD., Prof; E.M Shilov, MD, PhD, Prof; V.V. Fomin, MD, PhD; S.V. Moiseev, MD, PhD, Prof; M.Yu. Shvetsov, MD; L.Yu. Yurkevich
Atherosclerotic stenosis of the sole functioning kidney artery in patient with diabetes mellitus type 2 as a variant of kidney multimorbidity inelderly
|
№1 / 2009
|
Yu.S. Milovanov, MD, PhD; L.V. Lysenko, MD, PhD, Prof; L.Yu. Milovanova, MD, I.A. Dobrosmislov, MD
Influence of low protein diet with balanced content of essential amino- and ketoacids and high-energetic nutrition mix, on renal failure progression of pre-dialysis chronic kidney disease caused by systemic diseases
|
№1 / 2009
|
M.M. Batiushin MD, PhD, Prof, E.S. Postnikova, MD, V.P. Terentiev MD, PhD, Prof, I.V. Dereviankina, MD
Correction of cerebro-renal syndrome in arterial hypertension with ischemic stroke: efficacy of eprosartan and hydrochlorothiazide
|
№1 / 2009
|
N.Yu. Borovkova, MD, N.N. Borovkov, MD, PhD, Prof, B.N. Sidnev, MD, E.O. Obuhova MD
Heart rate variability, plasma renin activity and aldosterone level in chronic glomerulonephritis with arterial hypertension and normal renal function
|
№1 / 2009
|
Li O.A., I.N. Bobkova, MD, PhD, L.V. Kozlovskaya, MD, PhD, Prof
Urine levels of matrix metalloproteinases and their inhibitors as the marker of activity of chronic glomerulonephritis
|
№1 / 2009
|
I.E. Chazova, MD., PhD., Prof; V.V. Fomin, MD., PhD.; E.M. Paltseva MD., PhD.
Direct renin inhibitor aliskiren – new opportunities of kidney protection at hypertensive patients
|
№1 / 2009
|